Concepedia

Keith Glover

KG

Statistics

Publications

5

Citations

412

H-Index

5

Active since

2013

Affiliations

Stanford University(Current)

Stanford Medicine

Nanjing Medical University

Keith Glover is an author at Stanford University specializing in medicine, pharmacology, and aneurysm wall pathology.

Publications per year

2013–2021

5

Publications

5

Metformin treatment status and abdominal aortic aneurysm disease progression

Naoki Fujimura, Jiang Xiong, Ellen Kettler et al. · Journal of Vascular Surgery · 2016 · 167 citations · Full text

, , +11

Peptide Inhibitor of CXCL4–CCL5 Heterodimer Formation, MKEY, Inhibits Experimental Aortic Aneurysm Initiation and Progression

Yasunori Iida, Baohui Xu, Haojun Xuan et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2013 · 93 citations · Full text

, , +13

Inhibition of VEGF (Vascular Endothelial Growth Factor)-A or its Receptor Activity Suppresses Experimental Aneurysm Progression in the Aortic Elastase Infusion Model

Baohui Xu, Yasunori Iida, Keith Glover et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2019 · 75 citations · Full text

, , +17

Rapamycin Limits the Growth of Established Experimental Abdominal Aortic Aneurysms

Martin Rouer, Baohui Xu, Haojun Xuan et al. · European Journal of Vascular and Endovascular Surgery · 2014 · 56 citations · Full text

, , +9

Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms

Hiroki Tanaka, Baohui Xu, Haojun Xuan et al. · Journal of the American Heart Association · 2021 · 21 citations · Full text

, , +17

1–5 of 5